Literature DB >> 18802429

Abnormal glucose metabolism in hypertensive mice with genetically interrupted gamma-melanocyte stimulating hormone signaling fed a high-sodium diet.

X-P Ni1, Michael H Humphreys.   

Abstract

BACKGROUND: Rodents with deficiency of or resistance to the proopiomelanocortin-derived peptide gamma-melanocyte stimulating hormone (gamma-MSH) develop marked salt-sensitive hypertension. We asked whether this hypertension was accompanied by abnormal glucose metabolism.
METHODS: gamma-MSH-deficient Pc2(-/-) mice, and resistant Mc3r(-/-) mice were studied acutely for measurement of blood pressure and glucose and insulin concentrations after > or =1 week of a high-sodium diet (HSD; 8% NaCl) compared to a normal-sodium diet (NSD; 0.4% NaCl). Mc3r(-/-) also underwent glucose tolerance test (GTT) and insulin tolerance test.
RESULTS: Both knockout strains were hypertensive and also exhibited fasting hyperglycemia and hyperinsulinemia on the HSD. Mc3r(-/-) mice on the HSD had impaired glucose tolerance and insulin-mediated glucose disposal compared to wild-type mice on either the HSD or the NSD, or to Mc3r(-/-) mice on the NSD.
CONCLUSIONS: These results indicate an interaction of interrupted gamma-MSH signaling with the HSD to cause hypertension on the one hand and abnormal glucose metabolism, with the characteristics of insulin resistance, on the other. Further study of the nature of this interaction should provide new insight into the mechanisms by which salt-sensitive hypertension and insulin resistance are linked.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802429      PMCID: PMC3035849          DOI: 10.1038/ajh.2008.290

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  15 in total

1.  Prevention of salt-induced hypertension by an analog of gamma-melanocyte-stimulating hormone in the rat.

Authors:  Xi-Ping Ni; Michael H Humphreys
Journal:  Am J Hypertens       Date:  2007-08       Impact factor: 2.689

Review 2.  The sympathetic nervous system and the metabolic syndrome.

Authors:  Giuseppe Mancia; Pascal Bousquet; Jean Luc Elghozi; Murray Esler; Guido Grassi; Stevo Julius; John Reid; Peter A Van Zwieten
Journal:  J Hypertens       Date:  2007-05       Impact factor: 4.844

3.  Serum- and glucocorticoid-inducible kinase 1 mediates salt sensitivity of glucose tolerance.

Authors:  Krishna M Boini; Anita M Hennige; Dan Yang Huang; Björn Friedrich; Monica Palmada; Christoph Boehmer; Florian Grahammer; Ferruh Artunc; Susanne Ullrich; Diana Avram; Hartmut Osswald; Peer Wulff; Dietmar Kuhl; Volker Vallon; Hans-Ulrich Häring; Florian Lang
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

4.  Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.

Authors:  M Furuta; H Yano; A Zhou; Y Rouillé; J J Holst; R Carroll; M Ravazzola; L Orci; H Furuta; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 5.  Cardiovascular and renal actions of melanocyte-stimulating hormone peptides.

Authors:  Michael H Humphreys
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-01       Impact factor: 2.894

Review 6.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.

Authors:  G M Reaven; H Lithell; L Landsberg
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

7.  Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2.

Authors:  M Furuta; R Carroll; S Martin; H H Swift; M Ravazzola; L Orci; D F Steiner
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

8.  Suppression of gamma-melanocyte-stimulating hormone secretion is accompanied by salt-sensitive hypertension in the rat.

Authors:  Haim Mayan; Xi-Ping Ni; Shlomo Almog; Michael H Humphreys
Journal:  Hypertension       Date:  2003-10-20       Impact factor: 10.190

9.  Insulin resistance in essential hypertension.

Authors:  E Ferrannini; G Buzzigoli; R Bonadonna; M A Giorico; M Oleggini; L Graziadei; R Pedrinelli; L Brandi; S Bevilacqua
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

10.  Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors.

Authors:  Gregory M Sutton; James L Trevaskis; Matthew W Hulver; Ryan P McMillan; Nathan J Markward; M Josephine Babin; Emily A Meyer; Andrew A Butler
Journal:  Endocrinology       Date:  2006-02-09       Impact factor: 4.736

View more
  5 in total

1.  A novel missense mutation in the signal peptide of the human POMC gene: a possible additional link between early-onset type 2 diabetes and obesity.

Authors:  Monica Mencarelli; Alessandra Zulian; Raffaella Cancello; Luisella Alberti; Luisa Gilardini; Anna Maria Di Blasio; Cecilia Invitti
Journal:  Eur J Hum Genet       Date:  2012-05-30       Impact factor: 4.246

Review 2.  Cardiovascular effects of melanocortins.

Authors:  Michael H Humphreys; Xi-Ping Ni; David Pearce
Journal:  Eur J Pharmacol       Date:  2011-01-01       Impact factor: 4.432

Review 3.  Melanocortin-3 receptors and metabolic homeostasis.

Authors:  Karima Begriche; Clemencé Girardet; Patricia McDonald; Andrew A Butler
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 4.  Neural melanocortin receptors in obesity and related metabolic disorders.

Authors:  Clemence Girardet; Andrew A Butler
Journal:  Biochim Biophys Acta       Date:  2013-05-13

5.  Evidence for a noradrenergic mechanism causing hypertension and abnormal glucose metabolism in rats with relative deficiency of gamma-melanocyte-stimulating hormone.

Authors:  Xi-Ping Ni; Claudia van Dijk; David Pearce; Michael H Humphreys
Journal:  Exp Physiol       Date:  2009-05-08       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.